An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction

NCT01846468 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Renal Insufficiency

Interventions

DRUG: LHW090
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals